€123.32
Your prediction
Agilent Technologies Inc. Stock
Agilent Technologies is a leading global manufacturer of measuring instruments, software, services, and solutions for chemical analysis, life sciences, diagnostics, and electronic testing. The company provides a broad range of products from laboratory equipment to genetic testing tools and clinical diagnostics. Agilent's instruments are widely used in research laboratories, pharmaceutical companies, and government agencies, making it a significant player in the life sciences industry. The company operates in more than 100 countries and has a history of innovation, having developed some of the world's first portable gas chromatographs and UV-Vis spectrophotometers. Agilent's stock is traded on the New York Stock Exchange under the symbol "A."
Pros and Cons of Agilent Technologies Inc. in the next few years
Pros
Cons
Performance of Agilent Technologies Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Agilent Technologies Inc. | -0.870% | -7.947% | -7.475% | -1.815% | -1.426% | 10.725% | 84.460% |
| QuidelOrtho Corp. | -0.550% | -10.448% | -20.160% | -56.385% | -46.918% | -66.512% | - |
| Boston Scientific | 0.000% | -1.550% | 2.651% | 34.963% | 23.445% | 85.999% | 103.460% |
| Illumina Inc. | 0.260% | -10.000% | -8.406% | -47.323% | -14.693% | -67.071% | -61.429% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon initial review, the financials of Agilent Technologies (US Symbol: A) from the Healthcare Equipment & Supplies industry appear to show steady growth and financial stability. The company has managed to increase its net income and total assets over the past few years, suggesting a strong and expanding financial position. This combined with a generally positive industry trend makes Agilent Technologies an interesting player in the healthcare equipment and supplies sector.
Pros
Revenue Growth: From 2020 to 2022, Agilent's total revenue increased from $5.34 billion to $6.85 billion, demonstrating consistent growth. This steady uptick in revenues suggests promising business prospects and an expanding market share in the industry.
Comments
News
Agilent Receives Scientists' Choice Awards for Sustainability
Agilent Technologies Inc. (NYSE: A) announces that it is the recipient of two 2023 Sustainability Scientists’ Choice awards — Sustainable Supplier of the Year and Sustainable Product of the Year
Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demonstrates that the assay meets the
Agilent Brings Great Science to Life at Analytica 2024
Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows. Analytica, the premier